Massachusetts Mutual Life Insuran has recently announced that it has increased stake in Invesco Ltd. (NYSE:IVZ) by 1.95%. After grabbing 81.33 million shares, the institutional investor is now in possession of 1.55 million shares of the Financial Company. The new investment brought the stake of investor firm to 17.88% having worth around $1.25 billion. Moreover, Trian Fund Management LP increased its share by 1.72 million to have a control over 55.76 million shares. And BlackRock Fund Advisors raised its holdings to 1.63 million shares by acquiring 28.03 million shares or 6.16% of the stake.
Invesco Ltd. (IVZ) concluded trading on 11/16/22 at a closing price of $18.80, with 5.6 million shares of worth about $105.3 million changed hands on the day. Half year performance of the stock remained positive as price took a surge of 4.56% during that period and on Wednesday the price saw a loss of about -2.74%. Currently the company’s common shares owned by public are about 457.00M shares, out of which, 367.05M shares are available for trading.
According to filings with the U.S. Securities and Exchange Commission (SEC), insiders took part in trade of the company’s stock for 85 times over the past 12 months. They bought 38,230,631 shares in 63 of the transactions. In 22 selling transactions, insiders dumped 890,414 shares.
Vanguard Total Stock Market Index, Vanguard Small Cap Index Fund, and Vanguard 500 Index Fund are the top 3 mutual funds which are holding stakes in Invesco Ltd. Vanguard Total Stock Market Index is currently holding 13.58 million shares of worth totaling $208.04 million. The company recently came buying 66190.0 shares which brought its stake up to 2.99% of the company’s outstanding shares. Vanguard Small Cap Index Fund bought 3383.0 shares, after which its hold over company’s outstanding shares expand to 2.54%, leaving 11.55 million shares with the mutual fund that have a worth of about $176.96 million. Vanguard 500 Index Fund, after buying 10.31 million shares, have now control over 2.27% of the stake in the company. It holds 2.58 million shares of worth $157.88 million.
Invesco Ltd. (NYSE: IVZ) started trading at $19.15, below -$0.18 from concluding price of the previous day. However, the stock later moved at a day high price of 19.24, or with a loss of -2.74%. Stock saw a price change of 18.16% in past 5 days and over the past one month there was a price change of 25.92%. Year-to-date (YTD), IVZ shares are showing a performance of -18.33% which decreased to -26.82% when we look at its performance for past 12 months. Over the period of past 52 weeks, stock dropped to lowest price of $13.20 but also hit the highest price of $26.16 during that period. The average intraday trading volume for Invesco Ltd. shares is 5.38 million. The stock is currently trading 16.64% above its 20-day simple moving average (SMA20), while that difference is up 19.88% for SMA50 and it goes to 2.75% higher than SMA200.
Massachusetts Mutual Life Insuran acquired 81.33 million shares of Invesco Ltd. having value of about $1.25 billion. Data submitted at the U.S SEC by Massachusetts Mutual Life Insuran revealed that the firm now holds 1.55 million shares in the company valued at close to $29188034.0, or have control over 1.95% stake in the company. Invesco Ltd. (NYSE: IVZ) currently have 457.00M outstanding shares and institutions hold larger chunk of about 87.90% of that. Holding of mutual funds in the company is about 39.74% while other institutional holders and individual stake holders have control over 46.01% and 32.73% of the stake respectively.
The stock has a current market capitalization of $8.11B and its 3Y-monthly beta is at 1.33. PE ratio of stock for trailing 12 months is 9.41, while it has posted earnings per share of $2.00 in the same period. It has a debt-to-equity ratio of 0.74. Volatility of a stock is a metric used to know how much the price of that stock is under influence and for IVZ, volatility over the week remained 6.21% while standing at 4.14% over the month.
Analysts are in expectations that Invesco Ltd. (IVZ) stock would likely to be making an EPS of $0.33 in the current quarter, while forecast for next quarter EPS is $0.34 and it is $1.75 for next year. For the current quarter EPS, analysts have given the company a lowest target $0.3 which is $0.39 at the higher side of the target for the same. When we compare those targets with actual EPS, we find that company posted an EPS of $0.78 in the same quarter a year ago. Stock’s fiscal year EPS is expected to rise by 164.10% while it is estimated to increase by 3.17% in next year. EPS is likely to shrink at an annualized rate of -10.21% for next 5-years, compared to annual growth of 7.80% made by the stock over the past 5-years.
Digging deeper we find that several firms have released their research notes about the support levels of the stock. Most recent of them is a note released by Credit Suisse on October 26, 2022 offering an Underperform rating for the stock and assigned a target price range of between $13 and $11.50 to it. Coverage by Credit Suisse stated Invesco Ltd. (IVZ) stock as a Neutral in their note to investors on October 19, 2022, suggesting a price target of $13 for the stock. On June 13, 2022, BMO Capital Markets Downgrade their recommendations, while on April 12, 2022, Keefe Bruyette Downgrade their ratings for the stock with a price target of $25. Stock get an Equal-weight rating from Morgan Stanley on January 26, 2022.